Draganfly (CSE: DFLY) has just announced today that it has been selected by Coldchain Technology Services, LLC to immediately develop and provide flight services of a robust vaccine delivery payload for use in critical regions for drone delivery of the COVID-19 vaccine. Coldchain Technology provides comprehensive solutions for healthcare supply chain management for multiple government and commercial clients, including the US Army, the Centers for Disease Control and Prevention, Reserve Component forces, Johnson & Johnson brands, Chicago Department of Public Health, and others and has been leading the deployment of COVID-19 vaccines throughout the United States.
The payload to be developed by DFLY is a sustainable thermal management system with capability to carry a minimum of 300 multi-doses or 100 single doses. It is being designed as part of a comprehensive delivery and logistics platform of which DFLY will operate to deliver COVID-19 vaccinations!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from DFLY of USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.